SCHEDULE 13G/A: Todd Morrison Discloses 9.3% Passive Stake in BioRestorative Therapies

Todd Hale Morrison has filed an amended Schedule 13G, revealing a 9.3% beneficial ownership stake in BioRestorative Therapies, Inc. as a passive investor.

Summary

• Todd Hale Morrison, a U.S. citizen, has filed an Amendment No. 1 to Schedule 13G regarding his beneficial ownership in BioRestorative Therapies, Inc.
• As of February 27, 2025, Mr. Morrison beneficially owned 645,000 shares of BioRestorative Therapies, Inc. common stock.
• This ownership represents approximately 9.3% of the Issuer's outstanding Common Stock.
• The percentage was calculated based on 6,919,919 shares of Common Stock outstanding as of November 12, 2024, as reported in the Issuer's Form 10-Q.
• Mr. Morrison holds shared voting power and shared dispositive power over all 645,000 shares.
• The filing indicates that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, consistent with a passive investment.

Sentiment

Score: 5

Explanation: The filing is a neutral, routine disclosure of a passive ownership stake, providing no explicit positive or negative operational or financial news about the company.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of a significant passive ownership stake by an individual investor in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape beyond the ownership structure of BioRestorative Therapies, Inc.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant individual shareholder's stake and confirms the passive nature of the investment, which typically does not imply immediate strategic changes or activist pressure.

Key Dates

Recommendation

Keywords

BioRestorative Therapies, BRTX, Todd Morrison, Schedule 13G, Beneficial Ownership, Passive Investment, SEC Filing, Common Stock, Shareholder Disclosure